Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
FAQs

Why are Bispecific Antibodies Better?

The effectiveness of double-target bispecific antibody or single-target double-epitope bispecific antibody may be superior to the combination of two single-target monoclonal antibodies.

A dual-target antibody-drug molecule may have fewer side effects than a single-target antibody-drug.

A dual-target antibody-drug molecule may solve the mechanism of action that combination drugs cannot solve.

Killing tumors induced by mediated immune cells; Blocking dual target signal, playing unique or repetitive functions, preventing effectively drug resistance; It has more substantial specificity, targets and reduces off-target toxicity. Reducing effectively the cost of treatment.